ReviewJournal of clinical medicine2019

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook.

Nora Möhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.